April 19 (Reuters) - Athenex Inc:
* ATHENEX, INC. RECEIVES U.S. FDA ORPHAN DRUG DESIGNATION FOR ORAXOL FOR THE TREATMENT OF ANGIOSARCOMA
* ATHENEX INC - WILL BE INITIATING ANGIOSARCOMA CLINICAL STUDY SOON Source text for Eikon: Further company coverage: